Semaglutide (GLP1-Sema / NN9535) is a lyophilized GLP-1 receptor agonist research peptide supplied by Nextday Peptides. Lot documentation / COA available — review the certificate for reported results.
Compound identity
- Names: Semaglutide, GLP1-Sema, GLP-1 S, NN9535
- Target (research): GLP-1 receptor agonist
- Form: Lyophilized powder
- Purity: As reported on the lot COA
Related research compounds
Neighbor incretin-pathway SKUs are
Tirzepatide (GLP2-Tirz) and
Retatrutide (GLP3-Reta).
Family index:
GLP and incretin research peptides.
Research use only
Laboratory and analytical applications only. Not for human or veterinary use. Not a drug, supplement, or consumer product.
FAQ
What is Semaglutide (GLP1-Sema)?
A synthetic GLP-1 receptor agonist research peptide (NN9535) supplied as lyophilized laboratory material only.
Do you provide a COA?
Lot documentation / COA available. Review the applicable certificate for reported test results and methodology. Nextday Peptides does not independently test each lot in-house.
Is this for human use?
No. All Nextday Peptides materials are research use only and are not for human or veterinary consumption.